פרטים כלליים
שם
Name
פלוקונאזול טבע ® 150 מ"ג
FLUCONAZOLE TEVA ® 150 MG
יצרן
TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY
בעל רישום
ABIC MARKETING LTD, ISRAEL
שימוש
צורת מינון
Dosage Form
קפסולות
CAPSULES
דרך מתן
Usage Form
פומי
PER OS
תמונה חסרה
מחירים לצרכן
תאור אריזה
FLUCONAZOLE T.CAP 150MG(1
כמות
0
מחיר לצרכן כולל מע"מ
₪21.48
חומר פעיל
חומר פעיל
כמות
150 MG
ATC
עדכון רישום
סוג עדכון
תאריך עדכון
31.05.2024
31.05.2024
12.01.2023
12.01.2023
17.08.2022
17.08.2022
17.01.2022
17.01.2022
19.08.2021
19.08.2021
19.11.2020
19.11.2020
התוויה מאושרת
Fluconazole is indicated in adults for the treatment of:• Cryptococcal meningitis.• Coccidioidomycosis.• Invasive candidiasis.• Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.• Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.• Candidal balanitis when local therapy is not appropriate.• Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.• Tinea unguinium (onychomycosis) when other agents are not considered appropriate.Fluconazole is indicated in adults for the prophylaxis of:• Relapse of cryptococcal meningitis in patients with high risk of recurrence.• Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.• To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).• Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation).Fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence. Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.
בסל הבריאות
לא
מספר רישום
138-70-31385-00
תנאי ניפוק
תרופה במרשם
מגבלות
ללא הגבלות